Head and neck second primary cancer rates in the human papillomavirus era: A population‐based analysis
- 12 May 2015
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 38 (S1) , E873-E883
Abstract
Background: Patients with head and neck cancer are at high risk for second primary malignancies. Human papillomavirus (HPV)‐driven tumors are generally high‐grade oropharyngeal cancers. We analyzed the incidence of second primary malignancy of the head and neck in patients with primary squamous cell carcinoma (SCC) of the head and neck and temporal trends in the HPV era.Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried for patients with SCC of the head and neck (range, 1973–2008). Cumulative incidence rates of second primary malignancy of the head and neck were compared based on competing risk analysis.Results: A total of 104,639 cases were included in this study, of which 4616 patients had second primary malignancy of the head and neck. Oropharyngeal cancer incidence increased over time. Estimated incidence rate/10,000 person‐years (105.5, 80.6, and 50.2 for 1973–1989, 1990–1999, and 2000–2008, respectively) and cumulative incidence rates (10‐year rates of 6.68%, 5.72%, and 4.59% for 1973–1989, 1990–1999, and 2000–2008, respectively) of second primary malignancies of the head and neck for patients with oropharyngeal cancer decreased over time (p < .001). The second primary malignancy of the head and neck incidence rate was significantly lower in patients with high‐grade oropharyngeal cancer from 2000 to 2008 (30.3 vs 65.5 and 54.6 from 1973–1989 and 1990–1999, respectively; p < .001).Conclusion: The incidence of second primary malignancy of the head and neck in patients with head and neck cancer has decreased over time. This is driven by lower rates in patients with high‐grade oropharyngeal cancer, is temporally related with increases in HPV‐associated oropharyngeal cancer, and suggests that incidence rates of second primary malignancy of the head and neck may be lower for HPV‐associated cancer. © 2015 Wiley Periodicals, Inc. Head Neck 38: E873–E883, 2016Keywords
This publication has 24 references indexed in Scilit:
- Second Cancer Incidence, Risk Factor, and Specific Mortality in Head and Neck Squamous Cell CarcinomaOtolaryngology–Head and Neck Surgery, 2013
- Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancersCancer, 2013
- Oral field cancerization: current evidence and future perspectivesOral and Maxillofacial Surgery, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal CancerJournal of Clinical Oncology, 2011
- Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registriesInternational Journal of Cancer, 2008
- Head and neck cancerThe Lancet, 2008
- Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinomaCancer, 2005
- Alcohol and oral cancerAlcohol, 2005
- Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factorCancer, 1994